تحميل...
Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis
BACKGROUND: Oral 5‐aminosalicylic acid (5‐ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. Previously, it was found that 5‐ASA drugs in doses of at least 2 g/day, were more effective than placebo but no more effective th...
محفوظ في:
| الحاوية / القاعدة: | Cochrane Database Syst Rev |
|---|---|
| المؤلفون الرئيسيون: | , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
John Wiley & Sons, Ltd
2016
|
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045743/ https://ncbi.nlm.nih.gov/pubmed/27101467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000543.pub4 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|